Breaking Ground in Cancer Research: Going Public w/ Dr Alan Taylor from Clarity Pharmaceuticals
With Stake, Australia's leading investing platform, I'm excited to share the sixth episode of 'Going Public' - a new monthly series giving you unique access to the entrepreneurs, founders and executives who've taken their business public.
Clarity Pharmaceuticals is a clinical-stage cancer biotech company based in Australia. The company specializes in developing radiopharmaceutical products that can be used to image and diagnose various types of cancer. Clarity Pharmaceuticals is actively involved in extensive research, development, and clinical stage evaluation of its portfolio of novel radiopharmaceutical products. It was recently listed on the ASX in 2021 under the ticker CU6.
DISCLAIMER:
Views expressed are those of the individual only. This does not constitute financial advice.
You can subscribe to the newsletter here: https://lnkd.in/e7C8akgj.
Follow Mark Bouris on Instagram, LinkedIn & YouTube.
See omnystudio.com/listener for privacy information.
See omnystudio.com/listener for privacy information.